Evaluation of the anti-anginal efficacy and safety of oral administration of ivabradine compared to placebo on top of a background therapy with a calcium antagonist (amlodipine or nifedipine) in patients with stable angina pectoris: A 6-week, randomised, double-blind, parallel-group, international, multicentre study.

Trial Profile

Evaluation of the anti-anginal efficacy and safety of oral administration of ivabradine compared to placebo on top of a background therapy with a calcium antagonist (amlodipine or nifedipine) in patients with stable angina pectoris: A 6-week, randomised, double-blind, parallel-group, international, multicentre study.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Amlodipine; Ivabradine; Nifedipine
  • Indications Angina pectoris
  • Focus Registrational; Therapeutic Use
  • Sponsors IRIS
  • Most Recent Events

    • 31 Jan 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 25 Jul 2012 Planned end date changed from 30 Jan 2012 to 31 Jan 2013 ISRCTN: Current Controlled Trials
    • 25 Jul 2012 Status changed from completed to recruiting as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top